Abstract
Etoposide, a chemotherapeutic poison of type IIA eukaryotic topoisomerases, promotes topoisomerase II to compact DNA by trapping DNA loops, creates DNA double-strand breaks, causes topo II to resist relocation, and pauses topisomerases’ ability to relax DNA supecoiling. Through these mechanisms, etoposide converts topoisomerase II into a roadblock to DNA processing.